Most of the HGF in HNSCC is expressed by tumor-associated fibroblasts (TAFs) in the tumor microenvironment as an ineffective proenzyme that must be enzymatically degraded by the cell surface protease, matriptase (Yamashita et al., 2022). The gene discussed is ST14; the disease is neoplasm.